WINTER PARK, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE:PINE) (the "Company") today announced updated year-to-date 2024 investment and disposition activities. 2024 Investment Activity During the third quarter, the Company acquired four net leased retail properties for $37.5 million at a weighted average initial cap rate of 8.8%. Three properties, all located in the greater Tampa Bay, FL area, were purchased for $31.4 million as a sale-leaseback transaction with a subsid ...

HOUSTON and LONDON, Aug. 2, 2024 /PRNewswire/ -- Second Quarter 2024 Highlights Net income: $924 million, $734 million excluding identified items(a) Diluted earnings per share: $2.82 per share; $2.24 per share excluding identified items EBITDA: $1.6 billion, $1.4 billion excluding identified items Cash from operating activities: $1.3 billion Increased quarterly dividend by 7% to $1.34 per share Returned $513 million to shareholders through dividends and share repurchases Taking additional actions to grow ...

文章核心观点 - 艾兰科动物健康公司(Elanco Animal Health Incorporated)开发的两款重要药物Zenrelia和Credelio Quattro正在等待美国食品药品监督管理局(FDA)审批[3] - 2024年6月27日,艾兰科公司宣布FDA预计无法在6月批准这两款药物,并且Zenrelia将带有安全性警示[3] - 由于这一消息,艾兰科股价在2024年6月26日至27日之间下跌超过21%[4] - 律所正在调查艾兰科公司及其高管是否向投资者做出了虚假或误导性陈述[4] 公司概况 - 艾兰科公司是一家开发动物疾病治疗产品的公司[3] - 公司两款重要管线产品Zenrelia和Credelio Quattro正在等待FDA审批[3] 行业概况 - 艾兰科公司开发的Zenrelia和Credelio Quattro是针对犬类皮肤病和寄生虫的治疗药物[3] - 这两款药物的审批进度对艾兰科公司的业务发展至关重要[3][4]

VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) -- MAG Silver Corp. (NYSE:MAG) ("MAG", or the "Company") announces the Company's unaudited consolidated financial results for the three months ended June 30, 2024 ("Q2 2024"). For details of the unaudited condensed interim consolidated financial statements of the Company for the three and six months ended June 30, 2024 ("Q2 2024 Financial Statements") and management's discussion and analysis for the three and six months ended June 30, 2024 ("Q1 202 ...

Millicom (Tigo) Q2 2024 Earnings Release Luxembourg, August 02, 2024 – Millicom is pleased to announce its second quarter 2024 results. Please find below links to the Q2 2024 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Q2 Highlights* Revenue $1.46 billion, up 4.7%Operating profit $345 million, up 74.1%   EBITDA $634 million, up 23.1% - Colombia EBITDA margin 39.5% Net income $78 million ($0.46 per share)Equity free cash flow $268 millionLeverage 2.77x Financial highlig ...

NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the "Company" or "FTAI Infrastructure") today reported financial results for the second quarter 2024. The Company's consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release. Financial Overview (in thousands, except per share data)Selected Financial ResultsQ2'24Net Loss Attributable to Stockholders$(54,350)Basic and Diluted Loss per Share of Common Stock$(0.52) ...

文章核心观点 - ZTO Express(Cayman)Inc.将于2024年8月20日在美国市场收盘后发布2024年第二季度和上半年的未经审计财务业绩[1] - ZTO Express将于2024年8月20日晚8:30(北京时间8月21日早上8:30)举行财报电话会议[2] - ZTO Express是中国领先和快速增长的快递公司,提供快递服务和其他增值物流服务[3] - ZTO Express采用高度可扩展的网络合作伙伴模式,以支持中国电子商务的显著增长[4] 根据相关目录分别进行总结 财务业绩 - ZTO Express将于2024年8月20日在美国市场收盘后发布2024年第二季度和上半年的未经审计财务业绩[1] - ZTO Express将于2024年8月20日晚8:30(北京时间8月21日早上8:30)举行财报电话会议[2] 公司概况 - ZTO Express是中国领先和快速增长的快递公司,提供快递服务和其他增值物流服务[3] - ZTO Express采用高度可扩展的网络合作伙伴模式,以支持中国电子商务的显著增长[4]

LOUISVILLE, Ky., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,730 million, up 26.0% compared to $2,167 million in the second quarter of 2023.Net income of $19.4 million, compar ...

SAN JUAN CAPISTRANO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of City Park Healthcare and Rehabilitation Center, a 125-bed skilled nursing facility located in Denver, Colorado. This acquisit ...

文章核心观点 - 化工公司Olin Corporation将于2024年12月12日在纽约市举办投资者日活动 [1][2][3] - 公司高管将介绍公司的战略愿景、业务深度分析、资本配置策略和长期财务目标 [2][3] - 活动将采取线上和线下的形式,线下参与需要提前注册 [3][4] 公司概况 - Olin Corporation是一家全球领先的化工产品和弹药制造商 [5] - 主要生产产品包括氯碱、乙烯、环氧树脂、有机氯化物、漂白剂、氢气和盐酸等化工产品 [5] - 旗下Winchester品牌是美国主要的运动弹药、执法弹药、再装组件、小口径军用弹药和工业弹药制造商 [5]